2023
Jensen I , Srivastava K, Minshall M, Kemp R. Estimating the lifetime burden of illness in patients with bronchiolitis obliterans syndrome. Abstract EE539 . ISPOR 2023.
View Abstract
Topics: bronchiolitis obliterans , cost-consequence , cost-utility analysis , Health Economics and Outcomes Research (HEOR)
Bean K, Miller B, Jensen I , Fields C, Pang F. Evaluating the face validity of health state utility values (HSUVS) for metachromatic leukodystrophy (MLD). Abstract EE285 . ISPOR 2023.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Bean K, Olaye A, Miller B, Jensen I , Dean R, Pang F. Direct cost analysis associated with the management of patients with metachromatic leukodystrophy (MLD) across nine European countries. Abstract EE408 . ISPOR 2023.
View Abstract
Topics: Metachromatic leukodystrophy (MLD)
Broome CM, Mitchell M , Bylsma L , Shara N, Fernandez S, Catlett J, Lai J, Dong K, Fryzek J, Daver N, Allen C. Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH). Poster presented to European Hematology Association, EHA2023, Abstract P1202, Frankfurt, June 2023.
View Abstract
Topics: Epidemiology , Rare Diseases
Broome CM, Mitchell M , Bylsma L , Shara N, Fernandez S, Catlett J, Lai J, Dong K, Fryzek J, Daver N, Allen C. Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH). Abstract P1202. Poster presented to European Hematology Association-EHA2023, Frankfurt, June 2023.
View Abstract
Topics: Epidemiology
Pundole X, Ju C-H, Bylsma LC , Hooda N , Movva N , Elkhouly E, Bebb DG, Fryzek J, et al. 2023. Prevalence of delta-like ligand 3 expression in small cell lung cancer. J Clinical Oncology 41:16_suppl e20618.
View Abstract
Topics: Cancer , Epidemiology
Wood CT, Walter E, Espinosa CM, Enriquez-Bruce ME, Budhecha S, Elliott A, Domachowske J, Daniels D, Wolf Z, Waddell E, Suh M, Fryzek J, Nelson CB. Seasonality of infant lower respiratory tract infections, including those caused by RSV, was altered during the COVID-19 pandemic: Results from four US health systems. Poster #642 at the Pediatric Academic Societies meeting, Washington, DC, April 2023.
Topics: Epidemiology
Suh M, Reichert H, Jiang X, Pastula ST, Movva N, Fryzek J, Simoes E. The burden of RSV and bronchiolitis in the US infant Medicaid population extends beyond the inpatient setting. Oral presentation to the Pediatric Academic Societies meeting, Washington, DC, April 2023.
Topics: Epidemiology
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr P , Sawyer E, Stephen CD, Eichler F. Substantial burden of illness and mortality in men with adrenomyeloneuropathy. Poster presentation at American Academy of Neurology Annual Meeting, April 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Minshall M, Emden M, McLin R, Kemp P, Pontenani F, Cardosi L, Sacks N . The cost of non-cystic fibrosis bronchiectasis (NCFB) in patients with commercial insurance or Medicare coverage in the US. Poster presentation, ISPOR, April 2023.
A Division of